Goldman Sachs’s Asterias Biotherapeutics Inc. Series A AST Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q4 | – | Sell |
-57,337
| Closed | -$75K | – | 4441 |
|
|
2018
Q3 | $75K | Sell |
57,337
-5,534
| -9% | -$7.24K | ﹤0.01% | 3992 |
|
|
2018
Q2 | $85K | Buy |
+62,871
| New | +$85K | ﹤0.01% | 4026 |
|
|
2018
Q1 | – | Sell |
-11,934
| Closed | -$27K | – | 4460 |
|
|
2017
Q4 | $27K | Sell |
11,934
-478
| -4% | -$1.08K | ﹤0.01% | 4082 |
|
|
2017
Q3 | $42K | Buy |
+12,412
| New | +$42K | ﹤0.01% | 4137 |
|
|
2017
Q2 | – | Sell |
-10,581
| Closed | -$36K | – | 4671 |
|
|
2017
Q1 | $36K | Buy |
+10,581
| New | +$36K | ﹤0.01% | 4259 |
|
|
2016
Q4 | – | Sell |
-49,525
| Closed | -$210K | – | 4733 |
|
|
2016
Q3 | $210K | Buy |
49,525
+9,550
| +24% | +$40.5K | ﹤0.01% | 3908 |
|
|
2016
Q2 | $96K | Buy |
+39,975
| New | +$96K | ﹤0.01% | 4138 |
|
|
2015
Q4 | – | Sell |
-27,781
| Closed | -$108K | – | 4841 |
|
|
2015
Q3 | $108K | Buy |
+27,781
| New | +$108K | ﹤0.01% | 4138 |
|
|
2015
Q2 | – | Sell |
-46,283
| Closed | -$312K | – | 4917 |
|
|
2015
Q1 | $312K | Buy |
46,283
+10,445
| +29% | +$70.4K | ﹤0.01% | 3612 |
|
|
2014
Q4 | $116K | Buy |
+35,838
| New | +$116K | ﹤0.01% | 4214 |
|